Home › Atrial Fibrillation › Utah › Salt Lake City
Atrial Fibrillation clinical trials in Salt Lake City, UT
7 studies for Atrial Fibrillation are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- University of Utah, Salt Lake City
Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
RecruitingPhase 4
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
RecruitingObservational study
- St. Mark's Hospital, Salt Lake City
BOdygUardian MOnitoriNg for ReCurrencE of AF
RecruitingObservational study
- St. Mark's Hospital, Salt Lake City
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RecruitingPhase 3
- University of Utah, Salt Lake City
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
RecruitingPhase 3
- University of Utah Healthcare, Salt Lake City
RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
RecruitingPhase 2
- University of Utah, Salt Lake City
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Cleveland, OH17 studies
- Boston, MA17 studies
- Atlanta, GA16 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI11 studies
- Cincinnati, OH10 studies
- Columbus, OH10 studies
- Pittsburgh, PA10 studies
- Orlando, FL9 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer22 studies
- Lung Cancer21 studies
- Melanoma21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.